Improving Profitability in the Science Business
First written in FY2016. 4 of 28 entries say "Worsened", first in FY2017-Q1. Latest entry: FY2024-Q2.
Olympus moved to the "Worse" side of this theme in 2016.
1 other company's latest entry also says "Other".
- FY2024-Q2First-half discontinued-business results updatedAnnual report
「Profit from discontinued operations was ¥216,296 million, an increase of ¥149,460 million year on year, due to the recognition of an approximately ¥349,000 million gain on the transfer of the Science business during the six months ended the second quarter.」
Following completion of the transfer of the Science business, profit from discontinued operations was ¥228,149 million, and the approximately ¥349,000 million gain on the transfer of the Science business drove up profit attributable to owners of the parent. - FY2023-Q3Updated third-quarter discontinued-operations resultsAnnual report
「Profit from discontinued operations 4,882 2,750」
In the FY2023-Q3 year-to-date period, with the Science business treated as a discontinued operation, profit from discontinued operations was ¥2,750 million. Costs of ¥8,165 million related to the spin-off of the Science business and strengthening of its management structure were recorded. - FY2023-Q2First-half discontinued-business results updatedAnnual report
「Profit from discontinued operations (△ indicates a loss) 4,081 △2,586」
In the FY2023-Q2 year-to-date period, with the Science business classified as a discontinued operation, the loss from discontinued operations was ¥2,586 million. Costs of ¥4,880 million related to the spin-off of the Science business and strengthening of its management structure were also recorded. - FY2023-Q1Quarterly Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥21.925 billion, down 11.7% year on year, and an operating loss of ¥1.609 billion, compared with operating income of ¥1.873 billion in the same period of the previous year.」
Updated the FY2023-Q1 results for the Science business, which showed lower revenue and a swing from operating income to an operating loss. - FY2022Full-Year Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥119.105 billion, up 24.2% from the previous fiscal year, and operating income of ¥17.526 billion, up 254.1%.」
Updated the FY2022 full-year results for the Science business, which showed a 24.2% increase in revenue and a 254.1% increase in operating income. - FY2022-Q3Third-Quarter Results UpdateAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥82.854 billion, up 23.8% year on year, and operating income of ¥11.361 billion, up 284.3%.」
Updated the FY2022-Q3 nine-month results for the Science business, which showed a 23.8% increase in revenue and a 284.3% increase in operating income. - FY2022-Q2First-half results updatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥53.161 billion, up 31.9% year on year, and operating income of ¥6.485 billion, up 2,808.1%.」
Updated the FY2022-Q2 first-half results for the Science business, which showed a 31.9% increase in revenue and a 2,808.1% increase in operating income. - FY2022-Q1Quarterly Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥24.829 billion, up 39.8% year on year, and operating income of ¥1.873 billion, compared with an operating loss of ¥1.604 billion in the same period of the previous year.」
Updated the FY2022-Q1 results for the Science business, which showed a 39.8% increase in revenue and a swing from an operating loss to operating income. - FY2021Full-Year Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥95.861 billion, down 8.9% from the previous fiscal year, and operating income of ¥4.949 billion, down 50.5%.」
Updated the FY2021 full-year revenue and operating income results for the Science business. - FY2021-Q2First-half results updatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥40.312 billion, down 19.0% year on year, and operating income of ¥223 million, down 95.9%.」
Updated the FY2021-Q2 first-half results for the Science business, which showed lower revenue and a substantial decline in operating income. - FY2021-Q1Updated quarterly swing to a lossAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥17.757 billion, down 21.5% year on year, and an operating loss of ¥1.604 billion, compared with operating income of ¥1.644 billion in the same period of the previous year.」
Updated the FY2021-Q1 results for the Science business, which showed lower revenue and a swing from an operating profit in the same period of the previous year to an operating loss. - FY2020Full-Year Results UpdatedAnnual report
「Consolidated revenue in the Science business was ¥10,518.9 million, up 0.9% from the previous fiscal year, and operating income was ¥999.7 million, up 22.9%.」
Updated the full-year revenue and operating income results for the Science business. - FY2020-Q3Third-Quarter Results UpdateAnnual report
「Consolidated revenue in the Science business was ¥7,663.6 million, up 4.6% year on year, and operating income was ¥800.9 million, up 61.5%.」
Updated the FY2020-Q3 nine-month results for the Science business, which showed higher revenue and operating income. - FY2020-Q2First-half results updatedAnnual report
「Consolidated revenue in the Science business was ¥4,973.9 million, up 5.1% year on year, and operating income was ¥538 million, up 92.1%.」
Updated the FY2020-Q2 first-half results for the Science business, which showed higher revenue and operating income. - FY2020-Q1Quarterly Results UpdatedAnnual report
「Consolidated revenue in the Science business was ¥2,261.3 million, up 7.2% year on year, and operating income was ¥164.4 million, compared with an operating loss of ¥382 million in the same period of the previous year.」
In the first quarter, revenue in the Science business increased 7.2% and swung from an operating loss in the same period of the previous year to operating income. - FY2019Full-Year Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥104.225 billion, up 4.2% from the previous fiscal year, and operating income of ¥8.135 billion, up 26.6%.」
Updated the FY2019 full-year revenue and operating income results for the Science business. - FY2019-Q3Third-Quarter Results UpdateAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥73.245 billion, up 4.6% year on year, and operating income of ¥4.958 billion, up 40.9%.」
Updated the FY2019-Q3 results for the Science business, which showed higher revenue and operating income. - FY2019-Q2First-half results updatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥47.304 billion, up 6.0% year on year, and operating income of ¥2.8 billion, up 122.8%.」
Updated the FY2019-Q2 results for the Science business, which showed higher revenue and operating income. - FY2019-Q1Quarterly Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥21.089 billion, up 5.6% year on year, and an operating loss of ¥382 million, compared with an operating loss of ¥584 million in the same period of the previous year.」
Updated the FY2019-Q1 results for the Science business, which showed higher revenue and a narrower operating loss. - FY2018Full-Year Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥100.016 billion, up 7.1% from the previous fiscal year, and operating income of ¥6.425 billion, up 8.4%.」
Updated the FY2018 full-year results for the Science business, which showed higher revenue and operating income. - FY2018-Q3Third-Quarter Results UpdateAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥70.002 billion, up 10.2% year on year, and operating income of ¥3.519 billion, up 88.4%.」
Updated the nine-month results for the Science business, which showed higher revenue and operating income. - FY2018-Q2First-half results updatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥44.619 billion, up 10.5% year on year, and operating income of ¥1.257 billion, compared with an operating loss of ¥199 million in the same period of the previous year.」
The first-half results for the Science business showed higher revenue and a swing from an operating loss to operating income. - FY2018-Q1Quarterly Results UpdatedAnnual report
「The Scientific Solutions business recorded consolidated revenue of ¥19.973 billion, up 7.3% year on year, and an operating loss of ¥584 million, compared with an operating loss of ¥1.068 billion in the same period of the previous year.」
The first-quarter results for the Science business showed higher revenue and a narrower operating loss than in the same period of the previous year. - FY2017WorsenedAnnual report
「Consolidated revenue in the Science business was ¥9,322.7 million, down 8.2% from the previous fiscal year, and operating income was ¥528 million, down 37.8% year on year.」
Full-year revenue in the Science business fell 8.2% and operating income fell 37.8%, resulting in lower profitability than in the previous year. - FY2017-Q3WorsenedAnnual report
「For the nine months ended the third quarter, revenue in the Science business was ¥6,328 million, down 13.9% year on year, and operating income was ¥1,274 million, down 77.1%.」
For the nine months ended the third quarter, revenue in the Science business fell 13.9% and operating income fell 77.1%, resulting in lower profitability year on year. - FY2017-Q2WorsenedAnnual report
「For the six months ended the second quarter, revenue in the Science business was ¥4,018.5 million, down 17.1% year on year, and the operating loss was ¥648 million, compared with operating income of ¥3,322 million in the same period of the previous year.」
The Science business swung from an operating profit in the same period of the previous year to an operating loss, while revenue also fell 17.1%. - FY2017-Q1WorsenedAnnual report
「Consolidated revenue in the Scientific Solutions Business was ¥18.395 billion, down 19.1% year on year, and the operating loss was ¥1.396 billion, compared with operating income of ¥760 million in the previous-year period.」
The Science business swung from an operating profit in the same period of the previous year to an operating loss in the current quarter, while revenue also fell 19.1%. - FY2016First statedAnnual report
「Operating income in the Scientific Solutions Business increased as a result of efficiency improvements, including cost reductions and the integration of sales locations.」
The company reported higher operating income as a result of efficiency improvements from cost reductions and the integration of sales locations.